Medical Breakthroughs
0 views
FDA gives accelerated approval to Eli Lilly's Alzheimer's drug donanemab
The U.S. Food and Drug Administration has granted accelerated approval to donanemab, an Eli Lilly monoclonal antibody for early-stage Alzheimer's disease. The decision gives patients and doctors…
1hr ago